ATLASModerna (MRNA) earnings date: Nov 6, 2026
Moderna (MRNA) reports earnings for the quarter ended Sep 30, 2026 on Fri, Nov 6, 2026, before the open. Analysts expect EPS of -$1.10.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on MRNA
| Last price | $221.72 (-0.5%) |
|---|---|
| Normal 1-day range (±1σ) | ±6.8% |
| Earnings beat history | Beat the EPS estimate in 5 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Moderna stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Moderna reports on Nov 6, 2026. One email the day before, with ATLAS’s read on Moderna. You can switch it off at any time.
Alert me before MRNA reportsFree to start. Creating an account takes under a minute.
MRNA earnings at a glance
| Next report (confirmed) | Fri, Nov 6, 2026 |
|---|---|
| Time | Before the open |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$1.10 |
| Last report | Jul 31, 2026 · Beat |
| Beat rate (last 5 reports) | 5 of 5 (100%) |
| Average EPS surprise | +50.9% |
| Average move around a report | ±3.6% (last 5) |
| Sector | Healthcare · Biotechnology |
Moderna earnings history: last 5 reports
Moderna last reported on Jul 31, 2026: EPS of -$1.97 against an estimate of -$2.06 (+4.4% surprise), a beat.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Jul 31, 2026 | -$2.06 | -$1.97 | +4.4% | Beat | -4.8% |
| May 22, 2026 | $1.34 | $1.78 | +32.8% | Beat | -0.5% |
| May 1, 2026 | -$3.88 | -$3.40 | +12.4% | Beat | +3.0% |
| Mar 17, 2026 | $0.42 | $0.65 | +54.8% | Beat | -1.7% |
| Mar 4, 2026 | $0.06 | $0.15 | +150.0% | Beat | +8.0% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for MRNA
See the fair value, the probability range and the earnings history of Moderna on its ATLAS page.
Moderna (MRNA) stock analysisPlans from €3.99 a month.
Moderna earnings: frequently asked questions
When does Moderna (MRNA) report earnings?
Moderna is scheduled to report on Friday, November 6, 2026, before the open. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for MRNA?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$1.10 per share (USD). Estimates can change before the report.
How often does MRNA beat earnings estimates?
Of its last 5 reports with a recorded result, Moderna beat the EPS estimate 5 times; the average surprise was +50.9%. Past results do not predict the next one.
How much does MRNA move around earnings?
Over its last 5 reports the stock moved an average of 3.6% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Moderna beat earnings estimates last quarter?
Moderna last reported on Jul 31, 2026: EPS of -$1.97 against an estimate of -$2.06 (+4.4% surprise), a beat.
How much does MRNA usually move in a day?
On a normal trading day the ATLAS model puts MRNA’s one-day range at about ±6.8%, with a 48% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Fri, Nov 6, 2026
Educational information, not investment advice. Disclaimer